See more : NeuroOne Medical Technologies Corporation (NMTC) Income Statement Analysis – Financial Results
Complete financial analysis of PT Cottonindo Ariesta Tbk (KPAS.JK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PT Cottonindo Ariesta Tbk, a leading company in the Apparel – Manufacturers industry within the Consumer Cyclical sector.
- Kan-Nanmaru Corporation (7585.T) Income Statement Analysis – Financial Results
- MetLife, Inc. (MET-PF) Income Statement Analysis – Financial Results
- CCC S.A. (CCC.WA) Income Statement Analysis – Financial Results
- Shanyuan Co., Ltd. (4416.TWO) Income Statement Analysis – Financial Results
- Apollo Strategic Growth Capital II (APGB) Income Statement Analysis – Financial Results
PT Cottonindo Ariesta Tbk (KPAS.JK)
About PT Cottonindo Ariesta Tbk
PT Cottonindo Ariesta Tbk manufactures and sells cotton products in Indonesia. The company offers cosmetic cotton products, such as facial cotton pads and cotton buds; medical cotton products, including cotton rolls, dental cotton, mini cotton balls, and cotton ball in various sizes; and industrial cotton products comprising cotton sliver, spunlace cotton pads, bleached cotton, and cotton rolls. It also provides cotton bud manufacturing machines. The company was founded in 1993 and is headquartered in Subang, Indonesia.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 66.10B | 74.88B | 73.29M | 80.11M | 81.72M | 70.35M |
| Cost of Revenue | 0.00 | 0.00 | 45.29B | 44.97B | 46.06M | 49.14M | 50.45M | 41.48M |
| Gross Profit | 0.00 | 0.00 | 20.82B | 29.91B | 27.23M | 30.97M | 31.27M | 28.87M |
| Gross Profit Ratio | 0.00% | 0.00% | 31.49% | 39.95% | 37.15% | 38.66% | 38.27% | 41.04% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 16.56M | 16.67M | 1.53M | 1.60M | 1.03M | 724.56K |
| Selling & Marketing | 0.00 | 0.00 | 1.43M | 2.20M | 3.58M | 4.83M | 16.17M | 16.19M |
| SG&A | 0.00 | 0.00 | 16.48B | 17.44B | 15.47M | 16.44M | 22.74M | 21.08M |
| Other Expenses | 0.00 | 0.00 | -1.07B | -481.55M | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 0.00 | 0.00 | 17.55B | 17.92B | 16.88M | 18.00M | 23.71M | 21.46M |
| Cost & Expenses | 0.00 | 0.00 | 62.84B | 62.88B | 62.94M | 67.14M | 74.16M | 62.94M |
| Interest Income | 0.00 | 0.00 | 54.27M | 11.73M | 8.90M | 9.04M | 6.39M | 6.68M |
| Interest Expense | 0.00 | 0.00 | 7.81B | 8.57B | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 228.49K | 236.56K | 8.70M | 7.35M | 7.92M | 6.61M | 6.94M | 6.52M |
| EBITDA | 0.00 | 0.00 | 11.38M | 19.34B | 18.32M | 20.42B | 14.93M | 14.14M |
| EBITDA Ratio | 0.00% | 0.00% | 18.11% | 25.83% | 25.00% | 25.06% | 18.27% | 20.11% |
| Operating Income | 0.00 | 0.00 | 3.27B | 11.99B | 10.40M | 13.47M | 7.99M | 7.62M |
| Operating Income Ratio | 0.00% | 0.00% | 4.94% | 16.02% | 14.19% | 16.81% | 9.77% | 10.84% |
| Total Other Income/Expenses | 0.00 | 0.00 | -8.22B | -10.51B | 1.43B | 3.92B | 1.16B | 721.79M |
| Income Before Tax | 0.00 | 0.00 | -4.96B | 1.49B | 1.44M | 3.93M | 1.17M | 729.42K |
| Income Before Tax Ratio | 0.00% | 0.00% | -7.50% | 1.99% | 1.97% | 4.91% | 1.43% | 1.04% |
| Income Tax Expense | 0.00 | 0.00 | -31.46M | 930.70M | 642.43K | 1.08M | 371.53K | 2.49K |
| Net Income | 0.00 | 0.00 | -4.90B | 570.92M | 800.15K | 2.86M | 796.76K | 731.90K |
| Net Income Ratio | 0.00% | 0.00% | -7.42% | 0.76% | 1.09% | 3.57% | 0.97% | 1.04% |
| EPS | 0.00 | 0.00 | -6.38 | 0.74 | 1.27 | 14.08 | 6.37 | 5.86 |
| EPS Diluted | 0.00 | 0.00 | -6.38 | 0.68 | 1.27 | 14.08 | 6.37 | 5.86 |
| Weighted Avg Shares Out | 0.00 | 0.00 | 768.04M | 768.02M | 630.04K | 203.01K | 125.00K | 125.00K |
| Weighted Avg Shares Out (Dil) | 0.00 | 0.00 | 768.04M | 834.98M | 631.61K | 203.01K | 125.00K | 125.00K |
Source: https://incomestatements.info
Category: Stock Reports